The international side is a long term bet but I would be surprised if it has any significant impact to current earnings. If anything, I would assume it adds to current losses, but should become a positive catalyst long term.
Israeli Prime Minister Benjamin Netanyahu rejected necessary permits to export medical cannabis from Israel to Germany and other EU-countries. Netanyahu is awaiting results of new clinical trials from the health ministry as well as a National Economic Council study before allowing Israeli growers to export medical cannabis produced under the health ministry’s supervision.
According to Netanyahu’s decision, medical cannabis from Israel will not be offered in German pharmacies for the foreseeable future. Patients, doctors, and policymakers alike had hoped to bridge the current bottlenecks in the supply chain with medicine from Israel. In December, the German federal government stated the import of cannabis cultivated from abroad is an option which is already being discussed in Israel on an inter-ministerial level. Now it seems the market will be split among a handful of Canadian producers and one Dutch company before Germany starts domestic production in 2020.